Arkolith/Insider Trading/GLUE/Form 4

Townson Sharon

Chief Scientific OfficerMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$119K
Net Open-Market Flow
-$119K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Option exercise(M)6K$6.14$37K74K
May 29, 2026Sell(S)6K$19.87$119K68K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 29, 2026Option exercise(M)6K—$0209K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-251395) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML